Tender antivirotika k léčbě infekce hcv ii. 2021-3452211

This tender with title Antivirotika k léčbě infekce HCV II. 2021 -- Antivirals for systemic use has been published on Bidding Source portal dated 02 Aug 2021 for the country of Czech Republic. It has been categorized on Antivirals for systemic use. For similar tenders you can see tenders mentioned below of this page.

Antivirals for systemic use

General Information

Czech Republic

Tender Title :

Antivirotika k léčbě infekce HCV II. 2021
Antivirals for systemic use

Tender Type :

Invitation for Bids

Reference No. :

2021/S 146-385573

Country :

Czech Republic

Province/City :

Czech Republic-Olomouc

Publish Date :

2 Aug 2021

Closing Date :

30 Aug 2021

Notice Language :

English

Tender Categories (CPVs) :

Antivirals for systemic use

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Antiviral drugs for the treatment of HIV infection, combination - 676083 Czech Republic Antiviral drugs for the treatment of HIV infection, combination - 646340 Czech Republic Supplies of medicinal products with a combination of active substances ELBASVIR AND GRAZOPREVIR 2024 - 577191 Czech Republic Supplies of medicinal products with a combination of active ingredients SOFOSBUVIR AND VELPATASVIR 2024 - 579188 Czech Republic Antivirals for systemic use – Antivirotika ATC skupiny J05A* - 540316 Czech Republic Antivirals for systemic use – Rilpivirin - Czech Republic Czech Republic Antivirals for systemic use – Glekaprevir a pibrentasvir - 335321-2024 Czech Republic Antivirals for systemic use – Rilpivirin - 299195-2024 Czech Republic Czechia - Antivirals for systemic use - Supplies of medicinal products with a combination of active substances EMTRICITABIN, TENOFOVIR-ALAFENAMIDE AND RILPIVIRIN - 284704-2024 Czech Republic Czechia - Antivirals for systemic use - Supplies of medicinal products with a combination of active substances EMTRICITABIN, TENOFOVIR-ALAFENAMIDE AND BICTEGRAVIR - 285313-2024 Czech Republic

Antivirotika k léčbě infekce HCV II. 2021

Antivirals for systemic use

General Information

Czech Republic

Similar Tenders

Antivirals for systemic use Tenders

Czech Republic Tenders

Europe Tenders

Tenders

info@biddingsource.com